NCT00517556View on ClinicalTrials.gov

Continuous Administration of Oral Contraceptive, Primary Dysmenorrhea

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

March 31, 2011

Study Completion Date

April 30, 2011

Conditions
Dysmenorrhea
Interventions
DRUG

CCOCP

(CCOCP) continuous treatment with Monophasic oral gestodene/ethinyl estradiol

DRUG

Traditional OCP

(traditional OCP) (21 active days/7 inactive days) treatment regimen

Trial Locations (1)

Unknown

Nova Gradiska General Hospital, Strossmayerova 17

All Listed Sponsors
lead

Milton S. Hershey Medical Center

OTHER

NCT00517556 - Continuous Administration of Oral Contraceptive, Primary Dysmenorrhea | Biotech Hunter | Biotech Hunter